Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin C Earp

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
CPT: Pharmacometrics & Systems Pharmacology|October 18, 2024
Landscape of regulatory quantitative systems pharmacology submissions to the U.S. Food and Drug Administration: An update reportJane P F Bai, Guansheng Liu, Miao Zhao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2016
Role of Quantitative Clinical Pharmacology in Pediatric Approval and LabelingNitin Mehrotra, Atul Bhattaram, Justin C Earp, et al.
Clinical Pharmacology and Therapeutics|December 31, 2025
Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug DevelopmentGeorgi I Kapitanov, Justin C Earp, Kapil Gadkar, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 4, 2016
Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working GroupPeter L Bonate, Malidi Ahamadi, Nageshwar Budha, et al.
The AAPS Journal|May 1, 2021
FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspectiveJane P F Bai, Brian J Schmidt, Kapil G Gadkar, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 23, 2016
Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-ResponseJustin C Earp, Nitin Mehrotra, Kristina E Peters, et al.
Clinical Pharmacokinetics|September 8, 2011
Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008Joo Yeon Lee, Christine E Garnett, Jogarao V S Gobburu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
CPT: Pharmacometrics & Systems Pharmacology|October 18, 2024
Landscape of regulatory quantitative systems pharmacology submissions to the U.S. Food and Drug Administration: An update reportJane P F Bai, Guansheng Liu, Miao Zhao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2016
Role of Quantitative Clinical Pharmacology in Pediatric Approval and LabelingNitin Mehrotra, Atul Bhattaram, Justin C Earp, et al.
Clinical Pharmacology and Therapeutics|December 31, 2025
Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug DevelopmentGeorgi I Kapitanov, Justin C Earp, Kapil Gadkar, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 4, 2016
Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working GroupPeter L Bonate, Malidi Ahamadi, Nageshwar Budha, et al.
The AAPS Journal|May 1, 2021
FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspectiveJane P F Bai, Brian J Schmidt, Kapil G Gadkar, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 23, 2016
Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-ResponseJustin C Earp, Nitin Mehrotra, Kristina E Peters, et al.
Clinical Pharmacokinetics|September 8, 2011
Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008Joo Yeon Lee, Christine E Garnett, Jogarao V S Gobburu, et al.
Pageof 3